Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria
Author:
Publisher
Informa UK Limited
Subject
Dermatology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference7 articles.
1. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria☆☆☆★
2. Gas chromatographic method for the determination of cetirizine in plasma
3. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis☆☆☆
4. Controlled Comparison of the Efficacy and Safety of Cetirizine 10 mg o.d. and Fexofenadine 120 mg o.d. in Reducing Symptoms of Seasonal Allergic Rhinitis
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An update on the use of antihistamines in managing chronic urticaria;Expert Opinion on Pharmacotherapy;2024-03-23
2. Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials;The Journal of Allergy and Clinical Immunology: In Practice;2023-08
3. The use of Cetirizine and Levocetirizine in patients with chronic urticaria and other allergic dermatoses: issues of dosage increasing and long-term use. Resolution of the Advisory Board;Russian Journal of Allergy;2022-10-07
4. Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials;BMC Pharmacology and Toxicology;2019-11-29
5. Evaluation and Management of Angioedema in the Emergency Department;Western Journal of Emergency Medicine;2019-07-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3